UnknownPhase 2NCT02486484

Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection

Studying Central retinal vein occlusion

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Rafic Hariri University Hospital
Principal Investigator
Ahmad M Mansour, MD
Chair, Department of Ophthalmology, RHUH
Intervention
ziv-aflibercept(drug)
Enrollment
100 enrolled
Eligibility
All sexes
Timeline
20152019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02486484 on ClinicalTrials.gov

Other trials for Central retinal vein occlusion

Additional recruiting or active studies for the same condition.

See all trials for Central retinal vein occlusion

← Back to all trials